US5041434A
(en)
*
|
1991-08-17 |
1991-08-20 |
Virginia Lubkin |
Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
|
DE4038128A1
(de)
*
|
1990-11-27 |
1992-06-04 |
Schering Ag |
8-en-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
|
US5958912A
(en)
*
|
1992-04-21 |
1999-09-28 |
The Schepens Eye Research Institute, Inc. |
Ocular therapy in keratoconjunctivitis sicca using topically applied androgens of TGF-β
|
US5352445A
(en)
*
|
1992-05-07 |
1994-10-04 |
Lavaux Joseph E |
Lavaux tear test lacrimal equilibration time (LET)
|
US5827245A
(en)
*
|
1992-07-16 |
1998-10-27 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Transdermal therapeutic system comprising the active subtance 17-β-Estradiol (Anhydrous)
|
US5830508A
(en)
*
|
1992-08-06 |
1998-11-03 |
Deo Corporation |
Composition for treating dry eye
|
US5290572A
(en)
*
|
1992-08-06 |
1994-03-01 |
Deo Corporation |
Opthalmic composition for treating dry eye
|
WO1994004155A1
(en)
*
|
1992-08-19 |
1994-03-03 |
Health Resource Institute, Ltd. |
Dehydroepiandrosterone therapy for the treatment of eye disorders
|
US5639743A
(en)
*
|
1992-11-13 |
1997-06-17 |
University Of Georgia Research Foundation |
Compositions and methods for treating exocrine gland atrophy
|
US5696166A
(en)
*
|
1995-10-31 |
1997-12-09 |
Yanni; John M. |
Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
|
WO1997020578A1
(en)
*
|
1995-12-04 |
1997-06-12 |
University Of Miami |
Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
|
AUPO427196A0
(en)
*
|
1996-12-19 |
1997-01-23 |
University Of Sydney, The |
A method for preventing or controlling cataract
|
ZA989513B
(en)
|
1997-10-21 |
1999-04-21 |
Alcon Lab Inc |
Compositions containing histamine H2 agonists and methods of use in treating dry eye
|
US6096733A
(en)
*
|
1998-12-10 |
2000-08-01 |
Virginia Lubkin |
Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
|
WO2000038663A2
(en)
|
1998-12-24 |
2000-07-06 |
Alcon Laboratories, Inc. |
Ep4 receptor agonists for treatment of dry eye
|
AU775189B2
(en)
|
1999-11-09 |
2004-07-22 |
Alcon Inc. |
Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
|
WO2001034550A2
(en)
|
1999-11-09 |
2001-05-17 |
Alcon Universal Ltd. |
15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
|
AU1101301A
(en)
|
1999-11-09 |
2001-06-06 |
Alcon Universal Limited |
2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use
|
CA2386636A1
(en)
|
1999-11-09 |
2001-05-17 |
Alcon, Inc. |
15-hydroxyeicosatetraenoic acid-related compounds and methods of use
|
ATE265996T1
(de)
|
1999-11-09 |
2004-05-15 |
Alcon Inc |
Tri-heteroatom-substituierte und zwei kohlenstoff homologe von 15-hete und verfahren zur verwendung
|
US6803385B2
(en)
|
1999-11-09 |
2004-10-12 |
Alcon, Inc. |
Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
|
US6458854B2
(en)
|
1999-11-09 |
2002-10-01 |
Alcon Universal Ltd. |
Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
|
JP2003514782A
(ja)
|
1999-11-09 |
2003-04-22 |
アルコン,インコーポレイテッド |
ドライアイの処置のためのリポキシンa4およびそのアナログ
|
PL356092A1
(en)
|
1999-11-09 |
2004-06-14 |
Alcon Inc. |
Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
|
US6552084B2
(en)
|
1999-11-09 |
2003-04-22 |
Alcon Universal Ltd. |
Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
|
WO2001034549A1
(en)
|
1999-11-09 |
2001-05-17 |
Alcon Universal Ltd. |
Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders
|
DE60007548T2
(de)
|
1999-11-09 |
2004-06-17 |
Alcon, Inc. |
Omega kettenmodifizierte hydroxyeicosatetraensäure derivate verwendbar in der behandlung der "trockenes auge" krankheit
|
AU1226001A
(en)
|
1999-11-09 |
2001-06-06 |
Alcon Universal Limited |
Phospholipids of hydroxyeicosatetraenoic acid-like derivatives
|
PT1228030E
(pt)
|
1999-11-09 |
2005-08-31 |
Alcon Inc |
Derivados benzenoidicos do acido 15-hidroxieicosatetraenoico e metodos para a sua utilizacao no tratamento das perturbacoes do olho seco
|
WO2001046134A1
(en)
|
1999-12-22 |
2001-06-28 |
Alcon Universal Ltd. |
6-KETO PROSTAGLANDIN F1α AND ANALOGS FOR TREATING DRY EYE
|
AUPR549901A0
(en)
|
2001-06-06 |
2001-07-12 |
Vital Health Sciences Pty Ltd |
Topical formulation containing tocopheryl phosphates
|
CA2426885C
(en)
*
|
2000-11-14 |
2010-06-29 |
Vital Health Sciences Pty Ltd |
Complexes of phosphate derivatives
|
MXPA03010634A
(es)
|
2001-05-21 |
2004-03-09 |
Alcon Inc |
Uso de inhibidores de proteasoma para tratar trastornos del ojo seco.
|
CA2447883A1
(en)
|
2001-05-21 |
2002-11-28 |
Alcon, Inc. |
Use of nf-kappa-b inhibitors to treat dry eye disorders
|
EP1392322A1
(en)
*
|
2001-05-21 |
2004-03-03 |
Alcon, Inc. |
Method of treating dry eye disorders
|
US6872382B1
(en)
|
2001-05-21 |
2005-03-29 |
Alcon, Inc. |
Use of selective PDE IV inhibitors to treat dry eye disorders
|
US7112588B2
(en)
*
|
2001-05-21 |
2006-09-26 |
Alcon, Inc. |
Use of proteasome inhibitors to treat dry eye disorders
|
US6645994B1
(en)
|
2001-06-01 |
2003-11-11 |
Alcon, Inc. |
Method of treating dry eye disorders
|
US6750250B1
(en)
|
2001-07-12 |
2004-06-15 |
Alcon, Inc. |
11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders
|
CN1547475B
(zh)
*
|
2001-07-27 |
2010-12-15 |
生命健康科学有限公司 |
含电子转移试剂的磷酸酯衍生物的皮肤制剂
|
WO2003028667A2
(en)
*
|
2001-10-04 |
2003-04-10 |
Cellegy Pharmaceuticals, Inc. |
Semisolid topical hormonal compositions and methods for treatment
|
WO2003030892A1
(en)
*
|
2001-10-11 |
2003-04-17 |
Alcon, Inc. |
Methods for treating dry eye
|
WO2003030894A1
(en)
*
|
2001-10-11 |
2003-04-17 |
Alcon, Inc. |
Methods for treating dry eye
|
US20030109509A1
(en)
*
|
2001-10-11 |
2003-06-12 |
Alcon, Inc. |
Methods for treating dry eye
|
EP1460995B1
(en)
*
|
2001-12-13 |
2010-11-10 |
Vital Health Sciences Pty Ltd. |
Transdermal transport of compounds
|
US6659985B2
(en)
|
2002-01-30 |
2003-12-09 |
Southern College Of Optometry |
Method to use transdermal administration of androgens to the adnexa of the eye
|
US20070213310A1
(en)
*
|
2002-04-01 |
2007-09-13 |
Laszlo Prokai |
Prodrugs for Use as Ophthalmic Agents
|
US7186707B2
(en)
*
|
2002-04-01 |
2007-03-06 |
University Of Florida |
Prodrugs for use as ophthalmic agents
|
AU2002950713A0
(en)
*
|
2002-08-09 |
2002-09-12 |
Vital Health Sciences Pty Ltd |
Carrier
|
MXPA05003063A
(es)
*
|
2002-09-20 |
2005-05-27 |
Alcon Inc |
Uso de inhibidores de la sintesis de citosina para el tratamiento de trastornos de ojos secos.
|
AU2003290776A1
(en)
*
|
2002-11-15 |
2004-06-15 |
Panaseca, Inc. |
Methods and compositions for alleviating dry eyes
|
WO2004069248A1
(en)
*
|
2002-12-09 |
2004-08-19 |
University Of Florida |
Prodrugs for use a ophthalmic agents
|
US20040248794A1
(en)
*
|
2002-12-20 |
2004-12-09 |
Yanni John M. |
Treatment of dry eye by restoring 15-lipoxygenase activity to ocular surface cells
|
ATE534384T1
(de)
*
|
2003-01-17 |
2011-12-15 |
Vital Health Sciences Pty Ltd |
Verbindungen mit proliferationshemmenden eigenschaften
|
AU2003901815A0
(en)
*
|
2003-04-15 |
2003-05-01 |
Vital Health Sciences Pty Ltd |
Phosphate derivatives
|
US7235556B2
(en)
*
|
2003-04-16 |
2007-06-26 |
Alcon, Inc. |
Methods of treating dry eye disorders
|
US20060281716A1
(en)
|
2004-03-03 |
2006-12-14 |
West Simon M |
Alkaloid formulations
|
CA2562356A1
(en)
|
2004-04-08 |
2005-10-27 |
Retmed Pty Ltd |
Treatment of ophthalmic conditions with mineralcorticoids
|
PL1744736T3
(pl)
*
|
2004-05-14 |
2010-03-31 |
Alcon Inc |
Sposób leczenia zespołu suchego oka i zapalenia błony naczyniowej oka
|
US7923471B2
(en)
*
|
2004-05-14 |
2011-04-12 |
Alcon, Inc. |
Method of treating dry eye disorders and uveitis
|
US7223737B1
(en)
|
2004-08-13 |
2007-05-29 |
Alcon, Inc. |
Method of treating dry eye disorders using glycosides
|
US20060128803A1
(en)
*
|
2004-12-14 |
2006-06-15 |
Alcon, Inc. |
Method of treating dry eye disorders using 13(S)-HODE and its analogs
|
US9161905B2
(en)
*
|
2005-01-12 |
2015-10-20 |
Ocular Research Of Boston, Inc. |
Dry eye treatment
|
EP1858523A1
(en)
*
|
2005-03-02 |
2007-11-28 |
Nascent Pharmaceutical, Inc. |
Combinaion therapy for topical application in the treatment of dry eye syndrome
|
JP2008531602A
(ja)
*
|
2005-03-03 |
2008-08-14 |
バイタル ヘルス サイエンシズ プロプライアタリー リミティド |
抗癌特性を有する化合物
|
WO2006132033A1
(ja)
|
2005-06-10 |
2006-12-14 |
Pola Chemical Industries Inc. |
新規トリテルペン酸誘導体及びそれを含有してなる皮膚外用剤
|
NZ565049A
(en)
*
|
2005-06-17 |
2012-02-24 |
Vital Health Sciences Pty Ltd |
A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
|
CA2631653A1
(en)
*
|
2005-12-23 |
2007-06-28 |
Vital Health Sciences Pty Ltd. |
Compounds having cytokine modulating properties
|
US7745461B1
(en)
|
2006-02-27 |
2010-06-29 |
Alcon Research, Ltd. |
Method of treating dry eye disorders
|
PL2374472T3
(pl)
|
2006-03-16 |
2018-11-30 |
Dyax Corp. |
Kompozycje i sposoby leczenia zaburzeń okulistycznych
|
US20080132475A1
(en)
*
|
2006-12-05 |
2008-06-05 |
Charles Gerald Connor |
Treatment for dry eye
|
US20080221070A1
(en)
*
|
2007-03-06 |
2008-09-11 |
Pierce William M |
Methods and compounds for the targeted delivery of agents to bone for interaction therewith
|
EP2129373B1
(en)
*
|
2007-04-02 |
2013-05-22 |
DSM IP Assets B.V. |
Use of genistein for treating dry eye syndrome
|
NZ582188A
(en)
*
|
2007-07-11 |
2012-03-30 |
Pfizer |
Pharmaceutical compositions and methods of treating dry eye disorders
|
US20090098136A1
(en)
*
|
2007-10-15 |
2009-04-16 |
Alcon Research, Ltd. |
Use of tnf receptor antagonists for treating dry eye
|
TW200927192A
(en)
*
|
2007-11-19 |
2009-07-01 |
Alcon Res Ltd |
Use of TRPV1 receptor antagonists for treating dry eye and ocular pain
|
US20100016264A1
(en)
*
|
2007-12-05 |
2010-01-21 |
Connor Charles G |
Treatment for dry eye using testosterone and progestagen
|
US8207226B1
(en)
|
2008-06-03 |
2012-06-26 |
Alcon Research, Ltd. |
Use of FAAH antagonists for treating dry eye and ocular pain
|
CN102317288A
(zh)
|
2009-02-13 |
2012-01-11 |
佛维雅制药公司 |
作为激酶抑制剂的[1,2,4]三唑并[1,5-a]吡啶
|
EP2496233A1
(en)
*
|
2009-11-06 |
2012-09-12 |
Alcon Research, Ltd. |
Nutritional supplements for relief of dry eye
|
US10071030B2
(en)
|
2010-02-05 |
2018-09-11 |
Phosphagenics Limited |
Carrier comprising non-neutralised tocopheryl phosphate
|
CA2794734C
(en)
|
2010-03-30 |
2017-12-12 |
Phosphagenics Limited |
Transdermal delivery patch
|
AR081960A1
(es)
|
2010-06-22 |
2012-10-31 |
Fovea Pharmaceuticals Sa |
Compuestos heterociclicos, su preparacion y su aplicacion terapeutica
|
US20120079612A1
(en)
*
|
2010-09-24 |
2012-03-29 |
West Virginia University |
Dry eye animal model
|
EP2685992A4
(en)
|
2011-03-15 |
2014-09-10 |
Phosphagenics Ltd |
AMINO-QUINOLINES AS KINASE INHIBITORS
|
CN110812486A
(zh)
*
|
2012-07-09 |
2020-02-21 |
华柏恩视觉研究中心 |
用于预防和/或治疗干眼症的组合物、方法和/或装置
|
US10507245B2
(en)
*
|
2012-07-19 |
2019-12-17 |
Luis Felipe Vejarano Restrepo |
Ophthalmic formulation and method for ameliorating presbyopia
|
EP3021857B1
(en)
*
|
2013-07-19 |
2018-03-21 |
The Johns Hopkins University |
Biomaterials comprising hyaluronic acid binding peptides and extracellular matrix binding peptides for hyaluronic acid retention and tissue engineering applications
|
CN114712308A
(zh)
|
2015-12-09 |
2022-07-08 |
磷肌酸有限公司 |
药物制剂
|
CA3032790A1
(en)
|
2016-06-20 |
2017-12-28 |
Novartis Ag |
Methods of treating dry eye disease using tnf.alpha. antagonists
|
AU2017381395A1
(en)
|
2016-12-21 |
2019-06-20 |
Phosphagenics Limited |
Process
|
US10843325B2
(en)
|
2017-03-08 |
2020-11-24 |
DePuy Synthes Products, Inc. |
Quick coupling apparatus on instrument handle
|